<DOC>
	<DOCNO>NCT00425854</DOCNO>
	<brief_summary>The purpose trial evaluate efficacy , safety pharmacokinetics BIBW 2992 , dual , irreversible EGFR- HER2-inhibitor , two cohort patient HER2-negative breast cancer failure three regimen prior chemotherapy .</brief_summary>
	<brief_title>An Open Label Phase II Trial BIBW 2992 Patients With HER2-negative Metastatic Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Inclusion criterion : Female patient age 18 year old Histologically proven breast cancer failure relapse three line chemotherapy include adjuvant , irrespective prior hormone therapy metastatic disease ( stage IV ) ; HER2negative patient ( HER2 1+ negative , HER2 2+ FISH negative ) At least one measurable tumour lesion ( RECIST ) ; Availability tumour sample Written inform consent consistent ICHGCP guideline local law Eastern Cooperative Oncology Group ( ECOG , R010787 ) performance score 0 2 . Exclusion criterion : Active infectious disease Gastrointestinal disorder may interfere absorption study drug chronic diarrhoea Serious illness , concomitant nononcological disease mental problem consider investigator incompatible protocol Active/symptomatic brain metastasis Cardiac leave ventricular function rest ejection fraction &lt; 50 % ( upper limit normal ) ANC le 1500/mm3 platelet count less 100 000/mm3 Bilirubin great 1.5 mg /dl ( &gt; 26 # 61549 mol /L , SI unit equivalent ) AST ALT great 2.5 time upper limit normal great 5 time upper limit normal case know liver metastasis Serum creatinine great 1.5 mg/dl ( &gt; 132 # 61549 mol/L , SI unit equivalent ) Patients sexually active unwilling use medically acceptable method contraception Pregnancy breastfeed Concomitant treatment investigational drug anticancertherapy study and/or past two/four week , prior first treatment trial drug . Concurrent treatment biphosphonates allow Previous treatment trastuzumab , EGFR , EGFR/HER2inhibitors patient unable comply protocol Active alcohol drug abuse Other malignancy within past 5 year</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>